Evidence map›Paper›PMID 42806990›Full record

ArticleFrontiers in oncology2026

Prehabilitation for patients undergoing neoadjuvant treatment: results of a single-center pilot study using an integrative medicine day clinic.

Svenja Klaus-Karwisch, Stephanie Otto, Paul Georg Werthmann, Ann-Kathrin Lederer, André Leopold Mihaljevic, Fynn Treiber, Lena Cihlar, Keanu Leins, Benjamin Mayer, Klaus Kramer

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Svenja Klaus-KarwischSection Integrative Medicine, Department of General and Visceral Surgery, Ulm University Medical Center, Ulm University, Ulm, Germany.
Stephanie OttoComprehensive Cancer Center Ulm (CCCU), Ulm University Hospital, Ulm, Germany.
Paul Georg WerthmannSection Integrative Medicine, Department of General and Visceral Surgery, Ulm University Medical Center, Ulm University, Ulm, Germany.
Ann-Kathrin LedererSection Integrative Medicine, Department of General and Visceral Surgery, Ulm University Medical Center, Ulm University, Ulm, Germany.
André Leopold MihaljevicDepartment of General, Visceral and Transplantation Surgery, University Hospital Tuebingen, Tübingen, Germany.
Fynn TreiberInstitute of Epidemiology and Medical Biometry, University Ulm, Ulm, Germany.
Lena CihlarInstitute of Epidemiology and Medical Biometry, University Ulm, Ulm, Germany.
Keanu LeinsInstitute of Epidemiology and Medical Biometry, University Ulm, Ulm, Germany.
Benjamin MayerUniversity Ulm, Ulm, Germany.
Klaus KramerSection Integrative Medicine, Department of General and Visceral Surgery, Ulm University Medical Center, Ulm University, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Oncological prehabilitation aims to strengthen cancer patients physically and mentally before treatment, yet it is not standard care. The Prehabilitation through an Integrative Medicine Day Clinic (PRIME-DC) study examined the feasibility of a multimodal program during neoadjuvant therapy prior to surgery. Material and methods: In this single-arm, mono-center interventional feasibility trial, patients attended a closed-group program once weekly for eight weeks (6.5-hour sessions) scheduled across the neoadjuvant treatment period. The curriculum integrated physical exercise, nutritional and naturopathic counseling, and Mind-Body Medicine practices. The primary outcome was program adherence, defined by attendance rate. Secondary outcomes included patient-reported measures of quality of life, anxiety, depression, fatigue, sleep, mindfulness, and physical fitness tests assessed at baseline and post-intervention. Patient satisfaction were evaluated at program completion. Results: Twenty-three of the 41 patients who were assessed for eligibility were enrolled, with an adherence rate of 69%. An exploratory within-group improvement in the 1-minute sit-to-stand test was observed from baseline to post-intervention (V1: 26.00 (22.00/34.00), V10a: 27.00 (24.99/34.00), 95% CI = 1.000 - 6.000, p = 0.02, r = 0.66), while other functional and patient-reported outcomes showed no statistically detectable within-group changes (p > 0.05). No study-related adverse events occurred. Patient satisfaction was assessed using a 17-item Likert scale (0-4). Overall, patients reported high levels of satisfaction (range: 0.00 - 1.88). Conclusion: This pilot feasibility study provides preliminary evidence that participation in an integrative prehabilitation day-clinic program may be associated with the preservation of physical and mental health during neoadjuvant treatment. The findings indicate good feasibility and acceptability, providing a strong rationale for further investigation in larger, controlled trials. Clinical trial registration: https://drks.de/search/de/trial/DRKS00028126, identifier DRKS00028126.

Indexed as

integrative oncologymind-body medicinemultimodal prehabilitationneoadjuvant treatmentsupportive care

Identifiers

PMID42806990
PMCPMC13616645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.